secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001628280-24-024811
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics furnishes investor presentation; no specific material updates disclosed in exhibit
--------------------------------------------------------------------------------

- Investor presentation title: 'Unique biology, Precision therapeutics, Broad impact' — no additional content provided.
- No financial results, pipeline updates, or guidance changes are included in this filing.
- The filing does not contain any material new information beyond the existence of the presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/0001628280-24-024811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/fhtx-20240523.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-024811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer